Klonetics Plant Science Inc. Receives Nursery Cultivation License from Health Canada
June 7th, 2021
KELOWNA, BC, June 7, 2021 /CNW/ – Klonetics Plant Science Inc is pleased to announce that the company has received its Health Canada Nursery Cultivation licence to produce cannabis starting materials available for sale to the cannabis industry in Canada. Its impressive 25,000 Square Foot state of the art facility in Kelowna will produce Ready to Flower plants at an industrial scale, providing 2.8 million ready to flower plants to the market annually and with capacity to reach over 4 million by 2022.
Klonetics’ cutting edge tissue culture technology combined with industry leading Canadian scientists, allows for the production of consistent and reliable cannabis plants that are certified to be free of viruses, viroids, fungus and bacteria. This provides Klonetics customers with the strongest foundation to assist in generating the highest quality flower. Klonetics has significantly invested in the future of cannabis science by working with top scientists including; Dr. Timothy Sharbel as Chief Scientist, Dr. Krin Mann as Chief Tissue Culture Scientist, and Dr. Marco Pellino as Research Manager. Through partnerships with the University of Saskatchewan, the University of British Columbia Okangan, Genome Prairie Canada and the National Research Council, Klonetics is strongly positioned to make significant advancements in cannabis breeding, genomic analysis, and research and development.
Klonetics also has the largest breeder-backed catalogue of cannabis cultivars in the world available to licensed producers and micro-cultivators. This Provides the opportunity for cultivators to access industry sought-after genetics delivered to their doors as well as access to breeders, facilitating productive long-term relationships.
Bringing Ready to Flower plants to the industry will help licensed producers increase their revenue by up to 30% by removing the need for mothering and cloning rooms and only growing flowering plants. Additionally, most licensed producers will be able to add additional grow cycles to their annual production by using Klonetics Ready to Flower plants.
David Brough, CEO of Klonetics commented:
“I am extremely proud of our team and I would like to thank them for their unwavering dedication to achieve this significant milestone. With the license in hand we now have the critical tool we needed to execute our vision. We have scoured the globe to partner with some of the most influential cannabis breeders. Our exclusive and certified breeder backed genetics catalogue brings the icons of the industry and their creations into one incredible collaboration. We are diligently working with our talented science team to unlock the catalogues true potential. We look forward to our role in improving profitability and efficiency in the cannabis industry in Canada and abroad.”
Klonetics Plant Science Inc is a licensed cannabis nursery based in Kelowna B.C. that provides cannabis starting materials to licensed producers and micro cultivators in Canada. Klonetics specializes in industrial-scale cannabis tissue culture propagation, Ready to Plant clone plantlets, Ready to Flower plants, advanced genomics and breeding. Klonetics offers the most extensive range of proprietary strains in the cannabis industry backed by breeders. Visit klonetics.ca to learn more.
SOURCE Klonetics Plant Science Inc.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.